Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: Q4QAA6
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 8 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0005524 | ATP binding | 5 | 8 |
GO:0008817 | corrinoid adenosyltransferase activity | 4 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 8 |
GO:0017076 | purine nucleotide binding | 4 | 8 |
GO:0030554 | adenyl nucleotide binding | 5 | 8 |
GO:0032553 | ribonucleotide binding | 3 | 8 |
GO:0032555 | purine ribonucleotide binding | 4 | 8 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 8 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 8 |
GO:0036094 | small molecule binding | 2 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043168 | anion binding | 3 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:0097367 | carbohydrate derivative binding | 2 | 8 |
GO:1901265 | nucleoside phosphate binding | 3 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 148 | 152 | PF00656 | 0.768 |
CLV_C14_Caspase3-7 | 291 | 295 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.320 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.532 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.307 |
CLV_NRD_NRD_1 | 328 | 330 | PF00675 | 0.312 |
CLV_NRD_NRD_1 | 372 | 374 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.500 |
CLV_PCSK_KEX2_1 | 195 | 197 | PF00082 | 0.317 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.295 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.288 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.500 |
CLV_PCSK_PC7_1 | 320 | 326 | PF00082 | 0.317 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.407 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 268 | 272 | PF00082 | 0.332 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.374 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.353 |
DEG_COP1_1 | 151 | 159 | PF00400 | 0.659 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.546 |
DOC_CKS1_1 | 254 | 259 | PF01111 | 0.517 |
DOC_MAPK_gen_1 | 324 | 333 | PF00069 | 0.517 |
DOC_MAPK_MEF2A_6 | 296 | 304 | PF00069 | 0.549 |
DOC_PP4_FxxP_1 | 303 | 306 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.805 |
DOC_USP7_MATH_1 | 235 | 239 | PF00917 | 0.579 |
DOC_USP7_MATH_1 | 362 | 366 | PF00917 | 0.546 |
DOC_WW_Pin1_4 | 253 | 258 | PF00397 | 0.517 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.764 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.583 |
LIG_14-3-3_CanoR_1 | 11 | 17 | PF00244 | 0.459 |
LIG_14-3-3_CanoR_1 | 328 | 334 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 346 | 351 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 354 | 361 | PF00244 | 0.500 |
LIG_14-3-3_CanoR_1 | 41 | 48 | PF00244 | 0.683 |
LIG_14-3-3_CanoR_1 | 92 | 98 | PF00244 | 0.551 |
LIG_Actin_WH2_2 | 209 | 226 | PF00022 | 0.556 |
LIG_BRCT_BRCA1_1 | 187 | 191 | PF00533 | 0.517 |
LIG_BRCT_BRCA1_1 | 355 | 359 | PF00533 | 0.556 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.542 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.517 |
LIG_FHA_1 | 340 | 346 | PF00498 | 0.574 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.549 |
LIG_FHA_2 | 146 | 152 | PF00498 | 0.757 |
LIG_FHA_2 | 330 | 336 | PF00498 | 0.573 |
LIG_FHA_2 | 338 | 344 | PF00498 | 0.536 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.553 |
LIG_KLC1_Yacidic_2 | 85 | 90 | PF13176 | 0.607 |
LIG_LIR_Apic_2 | 275 | 280 | PF02991 | 0.533 |
LIG_LIR_Gen_1 | 200 | 209 | PF02991 | 0.496 |
LIG_LIR_Gen_1 | 85 | 95 | PF02991 | 0.583 |
LIG_LIR_Gen_1 | 96 | 104 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 200 | 206 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 356 | 361 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 93 | 98 | PF02991 | 0.500 |
LIG_MLH1_MIPbox_1 | 355 | 359 | PF16413 | 0.556 |
LIG_PCNA_PIPBox_1 | 330 | 339 | PF02747 | 0.556 |
LIG_PCNA_PIPBox_1 | 352 | 361 | PF02747 | 0.551 |
LIG_SH2_GRB2like | 351 | 354 | PF00017 | 0.546 |
LIG_SH2_PTP2 | 88 | 91 | PF00017 | 0.607 |
LIG_SH2_STAP1 | 341 | 345 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 341 | 344 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.556 |
LIG_SH3_3 | 251 | 257 | PF00018 | 0.556 |
LIG_SUMO_SIM_anti_2 | 15 | 21 | PF11976 | 0.424 |
LIG_SUMO_SIM_par_1 | 329 | 335 | PF11976 | 0.501 |
LIG_SUMO_SIM_par_1 | 50 | 56 | PF11976 | 0.634 |
LIG_UBA3_1 | 103 | 108 | PF00899 | 0.607 |
MOD_CDK_SPK_2 | 6 | 11 | PF00069 | 0.583 |
MOD_CDK_SPxxK_3 | 253 | 260 | PF00069 | 0.556 |
MOD_CK1_1 | 142 | 148 | PF00069 | 0.795 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.505 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.594 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.603 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.627 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.323 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.430 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.407 |
MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.317 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.727 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.745 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.642 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.467 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.514 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.741 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.497 |
MOD_LATS_1 | 344 | 350 | PF00433 | 0.556 |
MOD_N-GLC_2 | 112 | 114 | PF02516 | 0.407 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.518 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.746 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.716 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.501 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.558 |
MOD_NEK2_2 | 319 | 324 | PF00069 | 0.556 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.310 |
MOD_PKA_2 | 319 | 325 | PF00069 | 0.556 |
MOD_PKA_2 | 353 | 359 | PF00069 | 0.517 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.556 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.424 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.641 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.551 |
MOD_Plk_4 | 249 | 255 | PF00069 | 0.527 |
MOD_Plk_4 | 346 | 352 | PF00069 | 0.505 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.553 |
MOD_ProDKin_1 | 253 | 259 | PF00069 | 0.517 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.763 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.581 |
MOD_SUMO_rev_2 | 161 | 167 | PF00179 | 0.761 |
MOD_SUMO_rev_2 | 66 | 76 | PF00179 | 0.681 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.551 |
TRG_ER_diArg_1 | 195 | 197 | PF00400 | 0.551 |
TRG_ER_diArg_1 | 328 | 330 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.700 |
TRG_Pf-PMV_PEXEL_1 | 67 | 72 | PF00026 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIC8 | Leptomonas seymouri | 52% | 100% |
A0A0S4KL87 | Bodo saltans | 43% | 100% |
A0A3Q8ID37 | Leishmania donovani | 92% | 100% |
A4HDT5 | Leishmania braziliensis | 81% | 100% |
A4I133 | Leishmania infantum | 92% | 100% |
E9AX70 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |